India's most comprehensive portal on pharmaceutical News, Tenders, Patents, Notifications, Projects, Stocks, Drugs & Medicines

Bayer submits marketing authorization application to EMA for elinzanetant to treat moderate to severe vasomotor symptoms

Join Pharma | Login

	Editorial


	A RIGHT STEP TOWARDS TB ERADICATION
	Wednesday, October 9, 2024
	The Union Health Ministry has recently approved introduction of the much anticipated BPaLM regimen for multi-drug-resistant tuberculosis (MDR-TB) as a highly effective and shorter treatment option.
	Past Editorial...

TODAY'S NEWS


10:00 [IST]	Bayer submits marketing authorization application to EMA for elinzanetant to treat moderate to severe vasomotor symptoms
09:00 [IST]	UK’s life sciences sector to receive a £279 million boost to tackle significant health challenges
08:30 [IST]	Dharmendra Pradhan announces 3 CoEs in AI in healthcare, agriculture and sustainable cities

more news >>

TOP NEWS


08:00 [IST]	DTAB recommends to do away with toxicity studies for intravenous infusions and injectables
08:00 [IST]	NABL launches new accreditation program for biobanking based on ISO 20387:2018 Standard
08:00 [IST]	NPPA fixes retail price of 20 new drugs
08:00 [IST]	Nanotechnology is revolutionizing the future of treatment & diagnosing of diseases: Prof NK Lohiya
08:00 [IST]	India's approach to spine health combines modern medicine and traditional practices
08:00 [IST]	NCCE recommends amendment of CE Act to allow physiotherapists to own and run clinics

more news >>

YESTERDAY'S NEWS


16:40 [IST]	MedGenome marks 10 years of genomics in India, works to further its research and diagnostics in disease prevention
15:50 [IST]	Ampath collaborates with Innocent Hearts Hospital to expand diagnostic services in Jalandhar
15:30 [IST]	HealthPlix gets HIPAA certification, reinforcing its efforts in patient data privacy and security
15:15 [IST]	C-CAMP with ICARS to support innovative solutions to address the challenge of AMR across the One Health domain
13:30 [IST]	Lupin introduces generic Pred Forte in United States
12:45 [IST]	USV introduces OnArni for management of heart failure

more news >>

INTERVIEW


Commitment to innovation drives Bioaltus Pharmaceuticals
Dr. Ankit Varshney, Founder & Director of Bioaltus Pharmaceuticals

Past Interviews...

	What's New?

Import of Bulk Drug and Intermediates (All Countries) During the year 2022-23 and From April 2023 to November 2023 Import of Drug Formulations and Biologicals During the year 2022-23 and From April 2023 to November 2023 Export of Drug Formulations and Biologicals During the year 2022-23 and From April 2023 to November 2023 1 Ml Ampuole (2)tab Naproxen500mg Ed Flurbiprofen Sodium 0.3 Percentage 5 Ml,foleys Catheter 2 Way Size 16 Fr,framycetin Sulphate Cre

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers